Evidence map›Paper›PMID 11927636›Full record

ArticleThe Journal of experimental medicine2002

Identification of the in vivo role of a viral bcl-2.

Shivaprakash Gangappa, Linda F van Dyk, Travis J Jewett, Samuel H Speck, Herbert W Virgin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Deletion of Murine Gammaherpesvirus GeneJournal of virology · 2020
    Article
  6. Article
  7. Article
  8. Host Tumor Suppressor p18Journal of virology · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shivaprakash GangappaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Linda F van Dyk
Travis J Jewett
Samuel H Speck
Herbert W Virgin
Washington University in St. Louis · USEmory University · US

Funding

TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
Control of Gammaherpesvirus ReplicationR01CA052004 · NCI · WASHINGTON UNIVERSITY · PI SPECK, SAMUEL H · 1990 to 2013
$4.1M
Regulation of Y-herpesvirus latency and tumorigenesisR01CA074730 · NCI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 1998 to 2007
$2.8M
Vascular Injury and Atherosclerosis During Herpesvirus *R01HL060090 · NHLBI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 1999 to 2005
$2.5M
REGULATION OF EBV TRANSCRIPTION IN BURKITTS LYMPHOMAR01CA058524 · NCI · WASHINGTON UNIVERSITY · PI SPECK, SAMUEL H · 1995 to 2009
$2.4M
VIRAL TRANSCRIPTION IN EBV TRANSFORMED HUMAN B CELLSR01CA043143 · NCI · WASHINGTON UNIVERSITY · PI SPECK, SAMUEL H · 1986 to 2006
$1.7M
MECHANISMS OF INTERFERON ACTION AGAINST CMVR01AI039616 · NIAID · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 1997 to 2001
$447k
KAPOSIS SARCOMA INDUCTION BY MURINE Y-HERPESVIRUS 68R55CA074730 · NCI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 1997 to 1997
–
NCI NIH HHS CA43143NCI NIH HHS CA52004NCI NIH HHS CA58524NCI NIH HHS CA74730NCI NIH HHS R01 CA043143NCI NIH HHS R01 CA052004NCI NIH HHS R01 CA058524NCI NIH HHS R01 CA074730NHLBI NIH HHS HL60090NHLBI NIH HHS R01 HL060090NIAID NIH HHS 5 T32 AI 07163NIAID NIH HHS AI39616NIAID NIH HHS T32 AI007163
6 · The paper itself

Abstract

Many gamma-herpesviruses encode candidate oncogenes including homologues of host bcl-2 and cyclin proteins (v-bcl-2, v-cyclin), but the physiologic roles of these genes during infection are not known. We show for the first time in any virus system the physiologic role of v-bcl-2. A gamma-herpesvirus v-bcl-2 was essential for efficient ex vivo reactivation from latent infection, and for both persistent replication and virulence during chronic infection of immunocompromised (interferon [IFN]-gamma(-/-)) mice. The v-cyclin was also critical for the same stages in pathogenesis. Strikingly, while the v-bcl-2 and v-cyclin were important for chronic infection, these genes were not essential for viral replication in cell culture, viral replication during acute infection in vivo, establishment of latent infection, or virulence during acute infection. We conclude that v-bcl-2 and v-cyclin have important roles during latent and persistent gamma-herpesvirus infection and that herpesviruses encode genes with specific roles during chronic infection and disease, but not acute infection and disease. As gamma-herpesviruses primarily cause human disease during chronic infection, these chronic disease genes may be important targets for therapeutic intervention.

Indexed as

Genes, bcl-2AnimalsCell LineGammaherpesvirinaeHerpesviridae InfectionsMiceMice, Inbred BALB CMutationOncogene ProteinsPolymerase Chain ReactionTime FactorsVirus ActivationVirus LatencyOncogene Proteins

Identifiers

PMID11927636
PMCPMC2193719
OpenAlexW2145407944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.